Profile Category: <span>Our People</span>

Home / Our People
Li-Xi Yang M.D., Ph,D
Profiles

Li-Xi Yang M.D., Ph,D

Dr Yang is Senior Scientist and Scientific Director of an integrated citywide graduate medical education program in radiation oncology at California Pacific Medical Center Research Institute. His research focus is on overcoming the challenges of multidrug resistance in cancer cells, and includes the study of novel second-generation derivatives, development of new anticancer drugs, chemoradiosensitizing agents,...

Shayne Gad Ph.D., D.A.B.T., A.T.S.,
Profiles

Shayne Gad Ph.D., D.A.B.T., A.T.S.,

Dr. Gad has 33 years experience as a toxicologist, statistical consultant, manager and consultant on research and development in biopharmaceuticals. Dr Gad has held multiple executive positions at Incara/Aeolus Pharmaceuticals, Synergen, Becton Dickinson, G.D. Searle, Allied Corporation, and Shell. Dr. Gad received his Ph.D. in Pharmacology and Toxicology from University of Texas, Austin.

Gerald Su
Profiles

Gerald Su

Previously, Gerald worked in New York, London, San Francisco and Washington D.C. in various finance and strategy positions, including as a consultant to the United Nations Development Programme, as Director of Corporate Development & Strategy for a Silicon Valley technology company, and as an investment banker with Salomon Brothers, where he focused on life science...

Raymond Su
Profiles

Raymond Su

Since 1973, Raymond has founded companies involved in health care, high technology, investment banking, real estate, and manufacturing across the Asia Pacific region. He is also the founder and chairman of the Yuren Foundation, which since 1995 has provided merit-based scholarships to hundreds of medical, nursing, and pharmacy students from disadvantaged communities across China. Raymond...

Trevor Blake
Profiles

Trevor Blake

Since 2003 Trevor has founded and managed companies dedicated to developing and commercializing treatments for orphan-status diseases. He sold his QOL Medical in 2010 to Cooper Capital. In 2012 his ANU Pharmaceutical Company formed a joint venture with PUMC Pharmaceuticals to create Neovia Oncology dedicated to overcoming the significant and unmet need of cancer multi-drug...